{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:31Z","timestamp":1791356191005,"version":"4.3.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,17]]},"DOI":"10.1097\/qad.0b013e32832d9b00","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T03:22:54Z","timestamp":1246245774000},"page":"1329-1340","source":"Crossref","is-referenced-by-count":53,"title":["Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes"],"prefix":"10.1097","volume":"23","author":[{"given":"Henrik","family":"Kloverpris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Thorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Vinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders E","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L","family":"Hentze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betina S","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge M","family":"Svane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gerstoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"Kronborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Fomsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J Exp Med"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1417","article-title":"HIV and SIV CTL escape: implications for vaccine design","volume":"4","author":"Goulder","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm0297-205","article-title":"Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus","volume":"3","author":"Borrow","year":"1997","journal-title":"Nat Med"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(00)80161-2","article-title":"Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses","volume":"12","author":"Chen","year":"2000","journal-title":"Immunity"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/JVI.76.9.4251-4259.2002","article-title":"Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon","volume":"76","author":"Rodriguez","year":"2002","journal-title":"J Virol"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.immuni.2006.09.005","article-title":"Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses","volume":"25","author":"Yewdell","year":"2006","journal-title":"Immunity"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ni1281","article-title":"Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes","volume":"7","author":"Frahm","year":"2006","journal-title":"Nat Immunol"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.187.10.1647-b","article-title":"Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides","volume":"187","author":"Gallimore","year":"1998","journal-title":"J Exp Med"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1128\/JVI.00155-08","article-title":"Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination","volume":"82","author":"Holtappels","year":"2008","journal-title":"J Virol"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1128\/JVI.02392-06","article-title":"Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication","volume":"81","author":"Friedrich","year":"2007","journal-title":"J Virol"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1099\/vir.0.19152-0","article-title":"Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes","volume":"84","author":"Corbet","year":"2003","journal-title":"J Gen Virol"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1600-0463.2007.apm_595.x","article-title":"Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals","volume":"115","author":"Thorn","year":"2007","journal-title":"APMIS"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/00002030-200212060-00004","article-title":"Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection","volume":"16","author":"Chouquet","year":"2002","journal-title":"AIDS"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1089\/aid.2007.0111","article-title":"Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine","volume":"23","author":"Andresen","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.4049\/jimmunol.169.11.6376","article-title":"Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection","volume":"169","author":"Boaz","year":"2002","journal-title":"J Immunol"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1034\/j.1600-0463.2003.11107813.x","article-title":"Clinical application of dendritic cells in cancer vaccination therapy","volume":"111","author":"Svane","year":"2003","journal-title":"APMIS"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.00221-07","article-title":"Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals","volume":"15","author":"Connolly","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/429340","article-title":"Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection","volume":"191","author":"Garcia","year":"2005","journal-title":"J Infect Dis"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/aid.1998.14.551","article-title":"A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients","volume":"14","author":"Kundu","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"Lu","year":"2004","journal-title":"Nat Med"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.163.3.1666","article-title":"Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy","volume":"163","author":"Chougnet","year":"1999","journal-title":"J Immunol"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-2478(98)00169-2","article-title":"Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses","volume":"66","author":"Sapp","year":"1999","journal-title":"Immunol Lett"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jviromet.2006.04.009","article-title":"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","volume":"136","author":"Rousseau","year":"2006","journal-title":"J Virol Methods"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/CJI.0b013e3181833818","article-title":"Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1\/2 trial","volume":"31","author":"Berntsen","year":"2008","journal-title":"J Immunother"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/JVI.77.4.2663-2674.2003","article-title":"Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection","volume":"77","author":"Malhotra","year":"2003","journal-title":"J Virol"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/JVI.75.9.4195-4207.2001","article-title":"Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes","volume":"75","author":"Wilson","year":"2001","journal-title":"J Virol"},{"key":"R30-5-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02788751","article-title":"The optimization of helper T lymphocyte (HTL) function in vaccine development","volume":"18","author":"Alexander","year":"1998","journal-title":"Immunol Res"},{"key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2230.2007.02453.x","article-title":"Combined treatment with intratumoral injection of dendritic cells and topical application of imiquimod for murine melanoma","volume":"32","author":"Lee","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"R32-5-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.0906-6705.2006.00414.x","article-title":"Immune response modifiers: mode of action","volume":"15","author":"Schiller","year":"2006","journal-title":"Exp Dermatol"},{"key":"R33-5-20210130","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J Exp Med"},{"key":"R34-5-20210130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"R35-5-20210130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"R36-5-20210130","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood.V99.7.2505","article-title":"Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS","volume":"99","author":"Kostense","year":"2002","journal-title":"Blood"},{"key":"R37-5-20210130","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med"},{"key":"R38-5-20210130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T-cell memory in tumor immunology and immunotherapy","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunol Rev"},{"key":"R39-5-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R40-5-20210130","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/JVI.02119-08","article-title":"Inactivated SIV-pulsed autologous fresh blood cells as an immunotherapy strategy","volume":"83","author":"Mason","year":"2009","journal-title":"J Virol"},{"key":"R41-5-20210130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tim.2008.09.001","article-title":"Rates of HIV immune escape and reversion: implications for vaccination","volume":"16","author":"Davenport","year":"2008","journal-title":"Trends Microbiol"},{"key":"R42-5-20210130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nri2357","article-title":"Impact of MHC class I diversity on immune control of immunodeficiency virus replication","volume":"8","author":"Goulder","year":"2008","journal-title":"Nat Rev Immunol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200907170-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:49Z","timestamp":1786039189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200907170-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,17]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832d9b00","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7,17]]}}}